Quick Answer
Replimune Group, Inc. reported Cash and Equivalents of $111.12 million for fiscal year 2025.
Replimune Group, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $111.12M | +49.2% |
| 2024 | $74.46M | -49.2% |
| 2023 | $146.59M | +38.4% |
| 2022 | $105.95M | -42.0% |
| 2021 | $182.52M | +206.8% |
| 2020 | $59.50M | +131.5% |
| 2019 | $25.70M | +46.2% |
| 2018 | $17.58M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $122.95M | -28.6% | +20.2% |
| September 30, 2025 | $102.30M | -9.9% | +5.1% |
| June 30, 2025 | $97.37M | -35.8% | -12.4% |
| March 31, 2025 | $111.12M | +49.2% | -35.5% |
| December 31, 2024 | $172.25M | +76.4% | +51.8% |
| September 30, 2024 | $113.49M | +49.3% | -25.2% |
| June 30, 2024 | $151.66M | +42.4% | +103.7% |
| March 31, 2024 | $74.46M | -49.2% | -23.8% |
- Replimune Group, Inc. showed an increase of +49.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, Replimune Group, Inc.’s cash and equivalents has grown by 532.0% (from $17.58 million to $111.12 million).
- The most recent figure is from Replimune Group, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: